Gelstat Corp
OTC:GSAC
ROE
Return on Equity
ROE, or Return on Equity, is a key financial ratio that measures a company's profitability. Specifically, it measures how many dollars of profit are generated for each dollar of shareholder's equity. A higher ROE indicates better financial performance and effective use of capital, making it a valuable metric for investors assessing a company's earning potential.
ROE Across Competitors
| Country | Company | Market Cap | ROE | ||
|---|---|---|---|---|---|
| US |
|
Gelstat Corp
OTC:GSAC
|
247.2k USD |
-27%
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
700.4B USD |
78%
|
|
| UK |
|
Dechra Pharmaceuticals PLC
LSE:DPH
|
440.4B GBP |
-4%
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
370.6B USD |
30%
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
2.1T DKK |
88%
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
211.1B CHF |
27%
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
186.2B CHF |
33%
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
164.4B GBP |
20%
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
191.3B USD |
39%
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
163.5B USD |
70%
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
133.1B USD |
9%
|
Gelstat Corp
Glance View
GelStat Corp. engages in the research, development, and commercialization of pharmaceutical products. The company is headquartered in Stuart, Florida. The firm is engaged in the development and marketing of over-the-counter (OTC) and other non-prescription consumer healthcare products. The firm offers various products, which include GelStat Migraine and GelStat Sleep. GelStat Migraine is a solution designed for the pain relief from migraine headaches. GelStat Migraine is a formulation based on the medicinal plant’s feverfew (tanacetum parthenium) and ginger (zingiber officinale). Feverfew and ginger contain various compounds, including sesquiterpene lactones and flavonoids. GelStat Sleep provides relief from sleep disorders and its associated symptoms.
See Also
ROE, or Return on Equity, is a key financial ratio that measures a company's profitability. Specifically, it measures how many dollars of profit are generated for each dollar of shareholder's equity. A higher ROE indicates better financial performance and effective use of capital, making it a valuable metric for investors assessing a company's earning potential.
Based on Gelstat Corp's most recent financial statements, the company has ROE of -26.5%.
You don't have any saved screeners yet